Antibody Library Technologies Market

Antibody Library Technologies Market

Global Market Study on Antibody Library Technologies: Phage Display Segment by Technology to Register a CAGR of 5.0% During 2016–2024

  • XPLREP4962

  • May, 2019

  • 157 Pages

  • Biotechnology

Collaborations and cross-licensing are the key strategies adopted by a majority of players in the global antibody library technologies market. In a new publication titled “Antibody Library Technologies Market: Global Industry Analysis and Forecast, 2016–2024,” the analysts at XploreMR have observed that antibodies being a most successful biotechnology drug class, pharmaceutical companies are striving to add antibodies to their pipeline in order to alleviate patent cliff. While studying the various market segments the expert team of analysts have noted that North America represents the most lucrative regional market, followed by Europe and APAC. Another key observation is that despite phage display being the fastest growing technology, yeast display system is becoming a choice of technology due to the improved quality of MAB obtained through it. This report provides useful information regarding transitions in the business value proposition of key players. For instance, MorphoSys AG has set a goal to build the most valuable biopharmaceutical pipeline in the biotech industry and in line with this, the company is shifting its focus from technology licensing to drug development.

Major deals in the global antibody library technologies market

  • In August 2016, Italy-based biotechnology company Philogen entered into a collaboration agreement with Janssen Biotech Inc. – a Johnson & Johnson Company
  • In April 2016, Adimab LLC announced the signing of a collaboration agreement with Takeda Pharmaceutical Company Ltd.
  • In January 2016, Adimab LLC licensed its proprietary antibody libraries to Merck KGaA, under which Merck will internalize the Adimab technology and apply it broadly across its R&D programs

Why are Antibody Libraries not widely perceived as research reagents?

Although the antibodies selected by in vitro method are very powerful, the technology is not widely perceived as a valuable research reagent. The primary reason is a patent situation, which limits the use of this technology to high margin therapeutic markets. In contrast, classical hybridoma technology was never patented and thus achieved widespread acceptance in academics as well as for commercial purposes within a short period of time. However, some of the phage display patents are about to expire in the next few years while some have already expired, which may result in wide acceptance of the new technology. This technology is largely unnoticed by the research community due to the dominance of traditional hybridoma technology in most of the markets. For instance, some of the commercially available monoclonal antibodies are actually obtained by phage display screening but are reformatted to resemble murine antibodies.

Purchase Options
Global Market Study on Antibody Library Technologies: Phage Display Segment by Technology to Register a CAGR of 5.0% During 2016–2024
Buy Now
Custom Market Research Services

Custom Market Research Services

xploreMR offers custom market reserch services that help clients to get information on their business scenario required where syndicated solutions are not enough

Why Choose XploreMR

Why Choose XploreMR
  • Analyst Support

    Our analysts go above and beyond to answer your specific queries. We are with you throughout the entire journey – from initial discussion to post-purchase.

  • Country-wise Analysis & Forecasting

    As we track markets at country-level, we are able to offer hard-to-find market intelligence in both developed and emerging countries.

  • High Quality At Competitive Pricing

    We believe high quality market research shouldn’t be out of reach for businesses. Our competitively-priced market research reports ensure businesses of all sizes have access to quality information

Antibody Library Technologies Market

Popular Reports

report
Preimplantation Genetic Testing Market Forecast, Trend Analysis & Competition Tracking – Global Market insights 2017 to 2022

Preimplantation genetic testing is done to find out specific genetic diseases within embryos. This testing is gaining lot of traction due to the increased risk of various diseases owing to the changin ...

report
Cell Lines Market Forecast, Trend Analysis & Competition Tracking: Global Market insights 2017 to 2022

Cell lines are used in various applications such as drug discovery, biochemistry, molecular biology, cancer diagnostics, etc. They have several benefits, to name a few, they are cost effective, easy t ...